Clinical Trials Browser

Phase 1 × parsatuzumab × Tumor-Agnostic × Clear all

NCT00909740 2022-12-12

A Study of the Safety and Pharmacokinetics of MEGF0444A Administered to Patients With Advanced Solid Tumors

Phase 1 Completed

Neoplasms